Get started
Author

Marie‐Claude Fournié‐Zaluski

Observed names: Fournie-Zaluski, M.-C., Fournie-Zaluski, M.C., Fournie-Zaluski, Mc, Fournié-Zaluski Marie Claude, Fournié-Zaluski Marie-Claude, M C FOURNIE-ZALUSKI, M C Fournie-Zaluski, M C Fournié-Zaluski, M FOURNIEZALUSKI, M ‐C Fournié‐Zaluski, M-C. FOURNIE-ZALUSKI, M. -C. Fournié-Zaluski, M. C. FOURNIE‐ZALUSKI, M. C. Foumie-zaluski, M. C. Fourni??-Zaluski, M. C. Fournie-Zaluski, M. C. Fournie‐Zaluski, M. C. Fournié-Zaluski, M. C. Fournié‐Zaluski, M.-C Fournie-Zaluski, M.-C. Fournie-Zaluski, M.-C. Fournié-Zaluski, M.C Fournie-Zaluski, M.C Fournié-Zaluski, M.C. FOURNIE-ZALUSKI, M.C. FOURNIÉ‐ZALUSKI, M.C. Fournie-Zaluski, M.C. Fourniezaluski, M.C. Fournié-Zaluski, M.‐C. FOURNIE‐ZALUSKI, M.‐C. FOURNIÉ‐ZALUSKI, M.‐C. Fournié‐Zaluski, MARIE-CLAUDE FOURNIE-ZALUSKI, MARIE‐CLAUDE FOURNIE‐ZALUSKI, MARIE‐CLAUDE FOURNIÉ‐ZALUSKI, MARIE‐CLAUDE ZALUSKI, MC Fournié-Zaluski, MC Fournié‐Zaluski, Marie-Claude FOURNIE-ZALUSKI, Marie-Claude Fournie Zaluski, Marie-Claude Fournie-Zaluski, Marie-Claude Fournié-Zaluski, Marie-Claude Fournié-Zaluski, Marie-Claudé Fournié-Zaluski, Marie-claude Fournie-zaluski, Marie-claude Fournié, Marie‐Claude Fournie‐Zaluski, M‐C. FOURNIÉ‐ZALUSKI, M‐C. Fournie‐Zaluski, M‐C. Fournié‐Zaluski
Observed institutions: Délégation Paris 5, Centre National de la Recherche Scientifique, École Polytechnique, Inserm, Collège de France, University of Virginia Health System, Institut de Biologie et de Chimie des Protéines, Laboratoire de Cristallographie et RMN Biologiques, Hôpital Cochin, Centre Paul Broca, Pharmaleads (France), Institut Cochin, Laboratoire de Chimie Organique, Université Paris Descartes, Pathologie vasculaire et endocrinologie rénale, University of Virginia, Université de Strasbourg, Université de Montréal, Université de Caen Normandie
OpenAlex ID: A5111550037
Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
1993 · B P Roques, F Noble, et al. · Pharmacological Reviews · 756
The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice
1980 · B. P. Roques, M. C. Fournié-Zaluski, et al. · Nature · 705
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
1996 · S Zini, M C Fournie-Zaluski, et al. · Proceedings of the National Academy of Sciences · 322
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers.
1992 · H De Rocquigny, C Gabus, et al. · Proceedings of the National Academy of Sciences · 289
Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain.
1986 · G Waksman, E Hamel, et al. · Proceedings of the National Academy of Sciences · 204
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain
2012 · Bernard P. Roques, Marie-Claude Fournié-Zaluski, et al. · Nature Reviews Drug Discovery · 194
Δ9‐tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect
2001 · Olga Valverde, Florence Noble, et al. · European Journal of Neuroscience · 173
Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes
1984 · Marie-Claude Fournie-Zaluski, Pierre Chaillet, et al. · European Journal of Pharmacology · 166
D‐Tyr—Ser—Gly—Phe—Leu—Thr, a highly preferential ligand for δ‐opiate receptors
1980 · Gilles Gacel, Marie-Claude Fournie-Zaluski, et al. · FEBS Letters · 164
PDF
Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACGCC)
1998 · Nelly Morellet, Hélène Déméné, et al. · Journal of Molecular Biology · 152
Radioimmunoassay of Methionine‐and Leucine‐enkephalins in Regions of Rat Brain and Comparison With Endorphins Estimated by a Radioreceptor Assay
1978 · C. Gros, P. Pradelles, et al. · Journal of Neurochemistry · 149
Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR
1994 · N. Morellet, H. de Rocquigny, et al. · Journal of Molecular Biology · 147
First large scale chemical synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7 in an active form
1991 · H. de Rocquigny, D. Ficheux, et al. · Biochemical and Biophysical Research Communications · 143
Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: A potential treatment of salt-dependent hypertension
2004 · Marie-Claude Fournie-Zaluski, Celine Fassot, et al. · Proceedings of the National Academy of Sciences · 134
Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation
1992 · Ana Baamonde, Valérie Daugé, et al. · European Journal of Pharmacology · 125
Selective Protection of Methionine Enkephalin Released from Brain Slices by Enkephalinase Inhibition
1981 · Gilles Patey, Sophie De La Baume, et al. · Science · 121
Conversion of Renal Angiotensin II to Angiotensin III Is Critical for AT 2 Receptor–Mediated Natriuresis In Rats
2007 · Shetal H. Padia, Brandon A. Kemp, et al. · Hypertension · 119
PDF
Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
1992 · F Noble, J M Soleilhac, et al. · Journal of Pharmacology and Experimental Therapeutics · 118
Expression of neutral endopeptidase (enkephalinase) in heterologous COS-1 cells. Characterization of the recombinant enzyme and evidence for a glutamic acid residue at the active site.
1988 · A Devault, C Nault, et al. · Journal of Biological Chemistry · 118
Aminopeptidase A contributes to the N‐terminal truncation of amyloid β‐peptide
2009 · Jean Sevalle, Audrey Amoyel, et al. · Journal of Neurochemistry · 108
Characterization of Glu350 as a Critical Residue Involved in the N-Terminal Amine Binding Site of Aminopeptidase N (EC 3.4.11.2): Insights into Its Mechanism of Action
1998 · Nathalie Luciani, Cynthia Marie-Claire, et al. · Biochemistry · 106
Differential Inhibition of Aminopeptidase A and Aminopeptidase N by New .beta.-Amino Thiols
1994 · Eric N. Chauvel, Catherine Llorens-Cortes, et al. · Journal of Medicinal Chemistry · 106
1H NMR structure and biological studies of the His23 .fwdarw. Cys mutant nucleocapsid protein of HIV-1 indicate that the conformation of the first zinc finger is critical for virus infectivity
1994 · H. Demene, C. Z. Dong, et al. · Biochemistry · 101
Potent antinociceptive effects of Kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats
1989 · V. Kayser, M.C. Fournie-Zaluski, et al. · Brain Research · 99
Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord.
1986 · S Bourgoin, D Le Bars, et al. · Journal of Pharmacology and Experimental Therapeutics · 98
Works count: 323
Citation count: 11,840
H-index: 60
I10-index: 201
Year
Topic
Type